| 摘要 |
The invention relates to the use of L-cysteine and/or derivatives thereof for producing a pharmaceutical composition to selectively protect non-malignant cells, and to an extracorporeal method for selectively protecting non-malignant cells during a treatment to induce the cell death of malignant cells. |
